If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.71    0.11 (6.87%)
Bid:
1.61
Ask:
1.72
Spread: 0.11 (6.832%)
Market Cap: £34.31m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Holding(s) in Company

16 Sep 2015 16:30

RNS Number : 2516Z
Quintain Estates & Development PLC
16 September 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Quintain Estates & Development Plc

GB0007184442

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

n/a

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

n/a

An event changing the breakdown of voting rights

n/a

Other (please specify):

n/a

3. Full name of person(s) subject to thenotification obligation: iii

UBS Investment Bank

UBS Group AG

4. Full name of shareholder(s)  (if different from 3.):iv

UBS AG London Branch

UBS Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14 September 2015

6. Date on which issuer notified:

16 September 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

7%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct xi

Indirect xii

Direct

Indirect

GB0007184442

36,535,275

36,535,275

-

-

37,834,447

-

7.19%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

-

-

-

-

-

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

-

-

-

-

 

-

Nominal

Delta

-

-

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,834,447

7.19%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

UBS Group AG is a group holding company for UBS Investment Bank business. Voting rights

are held through its controlled undertakings as set out below.

 

UBS AG:

- directly through its branches: UBS AG London Branch - 35,534,192 (6.75%); and

- indirectly through its subsidiaries: UBS Limited - 2,300,255 (0.44%)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Konstantina Georgaki / Zuzana Görögová

15. Contact telephone number:

+41 44 239 4071

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMMGMLMVLGKZM
Date   Source Headline
26th Nov 20091:04 pmBUSDisclosure of Short Position
26th Nov 200912:59 pmBUSDisclosure of Short Position
24th Nov 200911:25 amRNSResult of General Meeting
18th Nov 20095:15 pmRNSHolding(s) in Company
16th Nov 20095:24 pmRNSHolding(s) in Company
10th Nov 20099:49 amRNSHolding(s) in Company
6th Nov 20093:05 pmRNSDirector/PDMR Shareholding
6th Nov 20093:01 pmRNSHolding(s) in Company
6th Nov 20092:20 pmBUSDisclosure of Short Position
5th Nov 200912:56 pmRNSPublication of Prospectus
5th Nov 20097:00 amRNSRights Issue
5th Nov 20097:00 amRNSHalf Yearly Results
4th Nov 20096:28 pmRNSHolding(s) in Company
3rd Nov 20095:48 pmRNSHolding(s) in Company
2nd Nov 20097:00 amRNSStatement re. Press Comment
13th Oct 20092:55 pmRNSDirector/PDMR Shareholding
12th Oct 20092:18 pmRNSHolding(s) in Company
9th Oct 20097:00 amRNSDisposal
1st Oct 20097:00 amRNSTrading Statement
30th Sep 200911:08 amRNSTotal Voting Rights
29th Sep 20091:20 pmRNSHolding(s) in Company
16th Sep 20092:18 pmRNSDirector/PDMR Shareholding
15th Sep 200910:12 amRNSHolding(s) in Company
11th Sep 20094:57 pmRNSHolding(s) in Company
11th Sep 20093:56 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSDisposal
9th Sep 20093:30 pmRNSResult of AGM
9th Sep 20099:45 amRNSDirectorate Change
2nd Sep 200912:42 pmRNSHolding(s) in Company
1st Sep 20093:31 pmRNSHolding(s) in Company
1st Sep 200912:01 pmRNSHolding(s) in Company
26th Aug 20093:48 pmRNSHolding(s) in Company
24th Aug 20095:09 pmRNSHolding(s) in Company
21st Aug 20093:37 pmRNSHolding(s) in Company
19th Aug 200911:52 amRNSDirector/PDMR Shareholding
18th Aug 200911:04 amRNSDirector/PDMR Shareholding
14th Aug 200911:00 amRNSAnnual Information Update
14th Aug 20099:43 amRNSHolding(s) in Company
13th Aug 20099:37 amRNSDirector/PDMR Shareholding
11th Aug 20099:14 amRNSDirector/PDMR Shareholding
7th Aug 200912:10 pmRNSDirector/PDMR Shareholding
31st Jul 200912:51 pmRNSTotal Voting Rights
29th Jul 20097:00 amRNSInterim Management Statement
28th Jul 20093:18 pmRNSNotice of IMS
16th Jul 20092:33 pmRNSDirector/PDMR Shareholding
16th Jul 200912:19 pmRNSDirector Declaration
15th Jul 20097:00 amRNSDirector/PDMR Shareholding
13th Jul 20092:45 pmRNSAnnual Financial Report
7th Jul 20092:20 pmRNSHolding(s) in Company
25th Jun 20095:17 pmRNSNotification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.